Xylem (NYSE:XYL) PT Raised to $142.00 at Oppenheimer

Xylem (NYSE:XYL) had its price target upped by equities researchers at Oppenheimer from $133.00 to $142.00 in a research note issued on Thursday, Benzinga reports. The firm presently has an “outperform” rating on the industrial products company’s stock. Oppenheimer’s price target would indicate a potential upside of 11.08% from the stock’s current price.

XYL has been the subject of several other reports. Stifel Nicolaus increased their price objective on Xylem from $136.00 to $150.00 and gave the company a “buy” rating in a research report on Wednesday, February 7th. Raymond James raised Xylem from an “underperform” rating to a “market perform” rating in a research report on Thursday, January 4th. BNP Paribas began coverage on Xylem in a research report on Tuesday, March 12th. They issued an “outperform” rating and a $150.00 price objective for the company. Royal Bank of Canada raised their target price on Xylem from $140.00 to $145.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 7th. Finally, Robert W. Baird raised their target price on Xylem from $141.00 to $148.00 and gave the stock an “outperform” rating in a research report on Thursday, March 21st. Four analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to data from MarketBeat.com, Xylem currently has a consensus rating of “Moderate Buy” and a consensus target price of $138.11.

Xylem Trading Up 0.5 %

Shares of XYL stock opened at $127.84 on Thursday. Xylem has a 12 month low of $87.59 and a 12 month high of $130.86. The company has a quick ratio of 1.30, a current ratio of 1.76 and a debt-to-equity ratio of 0.22. The business’s 50 day moving average is $127.01 and its two-hundred day moving average is $112.36. The company has a market cap of $30.99 billion, a PE ratio of 47.00, a price-to-earnings-growth ratio of 2.52 and a beta of 1.10.

Xylem (NYSE:XYL) last announced its quarterly earnings results on Tuesday, February 6th. The industrial products company reported $0.99 EPS for the quarter, beating the consensus estimate of $0.96 by $0.03. Xylem had a return on equity of 9.65% and a net margin of 8.27%. The company had revenue of $2.12 billion for the quarter, compared to the consensus estimate of $2.05 billion. During the same quarter last year, the company posted $0.92 earnings per share. The company’s revenue for the quarter was up 40.6% compared to the same quarter last year. Equities analysts predict that Xylem will post 4.13 EPS for the current year.

Insider Activity

In other news, SVP Franz Cerwinka sold 2,408 shares of the firm’s stock in a transaction on Thursday, February 8th. The stock was sold at an average price of $121.79, for a total value of $293,270.32. Following the completion of the sale, the senior vice president now directly owns 11,750 shares in the company, valued at $1,431,032.50. The sale was disclosed in a filing with the SEC, which is accessible through this link. In other news, CAO Geri-Michelle Mcshane sold 1,000 shares of the firm’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total value of $122,890.00. Following the completion of the sale, the chief accounting officer now directly owns 2,935 shares in the company, valued at $360,682.15. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, SVP Franz Cerwinka sold 2,408 shares of the firm’s stock in a transaction on Thursday, February 8th. The shares were sold at an average price of $121.79, for a total value of $293,270.32. Following the completion of the sale, the senior vice president now owns 11,750 shares of the company’s stock, valued at $1,431,032.50. The disclosure for this sale can be found here. 0.27% of the stock is currently owned by corporate insiders.

Institutional Trading of Xylem

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in XYL. Panagora Asset Management Inc. increased its position in Xylem by 21.7% in the first quarter. Panagora Asset Management Inc. now owns 14,297 shares of the industrial products company’s stock worth $1,219,000 after purchasing an additional 2,550 shares during the period. Yousif Capital Management LLC boosted its holdings in Xylem by 1.5% during the first quarter. Yousif Capital Management LLC now owns 27,307 shares of the industrial products company’s stock worth $2,328,000 after buying an additional 416 shares during the last quarter. Blair William & Co. IL boosted its holdings in Xylem by 0.5% during the first quarter. Blair William & Co. IL now owns 66,243 shares of the industrial products company’s stock worth $5,648,000 after buying an additional 299 shares during the last quarter. Sei Investments Co. boosted its holdings in Xylem by 6.7% during the first quarter. Sei Investments Co. now owns 335,330 shares of the industrial products company’s stock worth $28,590,000 after buying an additional 21,165 shares during the last quarter. Finally, Prudential PLC bought a new position in Xylem during the first quarter worth about $333,000. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.